| __timestamp | Apellis Pharmaceuticals, Inc. | Biogen Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 1893422000 |
| Thursday, January 1, 2015 | 13730311 | 2012800000 |
| Friday, January 1, 2016 | 22978599 | 1973300000 |
| Sunday, January 1, 2017 | 40303878 | 2253600000 |
| Monday, January 1, 2018 | 105285576 | 2597200000 |
| Tuesday, January 1, 2019 | 220968770 | 2280600000 |
| Wednesday, January 1, 2020 | 299921000 | 3990900000 |
| Friday, January 1, 2021 | 420869000 | 2501200000 |
| Saturday, January 1, 2022 | 387236000 | 2231100000 |
| Sunday, January 1, 2023 | 354387000 | 2702600000 |
| Monday, January 1, 2024 | 2041800000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are pivotal. Over the past decade, Biogen Inc. and Apellis Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D expenditures. Biogen, a stalwart in the industry, consistently allocated substantial resources, peaking in 2020 with an investment nearly double its 2014 figures. This reflects a robust commitment to innovation, with an average annual growth of 5% in R&D spending.
Conversely, Apellis Pharmaceuticals, a relatively newer player, exhibited a meteoric rise in R&D investments, surging by over 4000% from 2014 to 2023. This aggressive strategy underscores Apellis's ambition to carve a niche in the competitive biotech sector. As we look to the future, these investment trends offer a glimpse into the strategic priorities of these companies, shaping the next wave of medical breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Biogen Inc.
Research and Development Investment: Biogen Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Investment: Biogen Inc. vs Corcept Therapeutics Incorporated
Biogen Inc. or MorphoSys AG: Who Invests More in Innovation?
Biogen Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Biogen Inc. and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and MorphoSys AG
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Supernus Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.